作者
Catherine F. Sinclair,Vaninder K. Dhillon,Steven P. Hodak,Jennifer H. Kuo,Kepal N. Patel,Jonathon O. Russell,Ralph P. Tufano
摘要
We commend the authors on their article entitled "Thyroid Radiofrequency Ablation-Thermal Effects on Recurrent Laryngeal Nerve Using Continuous Intraoperative Neuromonitoring Animal Model,"1 which evaluates heat spread parameters for laryngeal nerve injury during radiofrequency ablation (RFA). The most significant finding was the lack of electrophysiologic data supporting the use of cold dextrose irrigation in the setting of periprocedural recurrent laryngeal nerve (RLN)/vagal injury. This finding is of particular importance given the mention of this rescue strategy in major North American guidelines,2, 3 raising questions as to whether this is a valid rescue strategy in the case of periprocedural dysphonia. However, there are significant limitations that limit the study's clinical relevance and applicability to in vivo human ablations. First, the spread of heat (SH) distance was determined by direct apposition of the electrode to connective tissue at varying distances (5, 3, 2, and 1 mm) from the lateral side of an exposed RLN after surgical removal of overlying thyroid/connective tissues. This absence of intervening tissues between the electrode tip and nerve may have artificially lowered or elevated observed SH thresholds, depending on whether those tissues usually attenuate or enhance (compared to air) SH. Second, 5 mm active tips are designed to be used at low power, not at 40 to 50 W as described in this study with potential effects on reported SH distances. As such, it is impossible to draw accurate SH conclusions for more commonly used 7 and 10 mm active tips at higher powers. A referenced study from 20214 utilized continuous nerve monitoring to document laryngeal nerve electrophysiology in humans undergoing thyroid RFA with electrode active-tip sizes 7 to 10 mm, concluding there is minimal thermal conduction to laryngeal nerves provided (a) the electrode tip remained 3 to 5 mm from the posterior thyroid capsule; (b) power was =40 W; and (c) the ablation field leading edge (defined as the furthermost point at which visual ablative changes were identified by ultrasound) did not touch the thyroid capsule. Similarly, in the current study, no significant neural events were noted when SH distances (at powers =50 W) were =5 mm. Pooling the results of these 2 studies, a practical safety paradigm for in vivo ablations with 7 to 10 mm active-tip electrodes would be to maintain a ≥5 mm distance from nerve danger zones up to 40 to 50 W. However, when ablating at higher powers, the additional safeguard of ensuring the leading edge does not touch the thyroid capsule should be implemented. Continuous auditory voice assessment to detect acute dysphonia is also an important danger-zone protective strategy, facilitating rapid identification of dysphonia and prompt cessation of heat delivery. Ultimately, however, only a laryngeal examination can verify the true outcomes of RLN palsy after ablation. Catherine F. Sinclair, letter design, conception, writing, review, submission; Vaninder Dhillon, letter design, conception, writing, review, submission; Steven Hodak, letter design, conception, writing, review, submission; Jennifer Kuo, letter design, conception, writing, review, submission; Kepal Patel, letter design, conception, writing, review, submission; Jonathon Russell, letter design, conception, writing, review, submission; Ralph Tufano, letter design, conception, writing, review, submission. Ralph Tufano—Consultant, RGS Healthcare. None.